Yüklüyor......
High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy
Background: Colorectal cancer is the third most common cancer in both sex worldwide and it is also the fourth most common cause of cancer mortality. For rectal cancer, neoadjuvant concurrent chemoradiotherapy (CCRT) followed by radical proctectomy is gold standard treatment for patients with stage I...
Kaydedildi:
| Yayımlandı: | J Cancer |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Ivyspring International Publisher
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5463434/ https://ncbi.nlm.nih.gov/pubmed/28607594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.18197 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|